Squarepoint Ops LLC Adicet Bio, Inc. Transaction History

Squarepoint Ops LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$0.76 - $1.09 $131,319 - $188,340	-172,789 Reduced 93.73%	11,567 $8,000
Q4 2024 Feb 14, 2025	BUY	$0.86 - $1.52 $158,546 - $280,221	184,356 New	184,356 $176,000
Q2 2024 Aug 14, 2024	BUY	$1.21 - $2.4 $422,804 - $838,620	349,425 Added 2728.82%	362,230 $438,000
Q1 2024 May 15, 2024	SELL	$1.76 - $3.45 $27,165 - $53,250	-15,435 Reduced 54.66%	12,805 $30,000
Q4 2023 Feb 14, 2024	BUY	$1.11 - $1.89 $18,742 - $31,912	16,885 Added 148.7%	28,240 $53,000
Q2 2023 Aug 14, 2023	SELL	$2.13 - $7.13 $9,020 - $30,195	-4,235 Reduced 27.16%	11,355 $27,000
Q1 2023 May 15, 2023	SELL	$5.52 - $9.23 $3,527 - $5,897	-639 Reduced 3.94%	15,590 $89,000
Q4 2022 Feb 14, 2023	BUY	$7.72 - $21.27 $125,287 - $345,190	16,229 New	16,229 $145,000

53.3M

27.2K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $25.6M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.